A carregar...
Taking aim at Alzheimer’s disease through the mammalian target of rapamycin
A significant portion of the world’s population suffers from sporadic Alzheimer’s disease (AD) with available present therapies limited to symptomatic care that does not alter disease progression. Over the next decade, advancing age of the global population will dramatically increase the incidence o...
Na minha lista:
| Publicado no: | Ann Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4250432/ https://ncbi.nlm.nih.gov/pubmed/25105207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.941921 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|